EPS (Basic)
Regeneron Pharmaceuticals EPS (Basic) decreased by 14.3% to $6.99 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $7.58 to $6.99. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows a downward trend with a -13.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Detailed definition
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Peer comparison
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
eps_basicHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.51 | $15.37 | $20.94 | $9.12 | $7.90 | $12.31 | $11.18 | $7.64 | $9.05 | $9.48 | $10.88 | $6.70 | $13.25 | $12.40 | $8.55 | $7.58 | $13.24 | $14.09 | $8.16 | $6.99 |
| QoQ Change | — | -47.9% | +36.2% | -56.4% | -13.4% | +55.8% | -9.2% | -31.7% | +18.5% | +4.8% | +14.8% | -38.4% | +97.8% | -6.4% | -31.0% | -11.3% | +74.7% | +6.4% | -42.1% | -14.3% |
| YoY Change | — | — | — | — | -73.2% | -19.9% | -46.6% | -16.2% | +14.6% | -23.0% | -2.7% | -12.3% | +46.4% | +30.8% | -21.4% | +13.1% | -0.1% | +13.6% | -4.6% | -7.8% |
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's eps (basic)?
- Regeneron Pharmaceuticals (REGN) reported eps (basic) of $6.99 in Q1 2026.
- How has Regeneron Pharmaceuticals's eps (basic) changed year-over-year?
- Regeneron Pharmaceuticals's eps (basic) decreased by 7.8% year-over-year, from $7.58 to $6.99.
- What is the long-term trend for Regeneron Pharmaceuticals's eps (basic)?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's eps (basic) has grown at a -13.3% compound annual growth rate (CAGR), from $76.40 to $43.07.
- What does eps (basic) mean?
- The amount of profit a company makes for every single share of its common stock currently held by investors.